BookBradley A. Maron, Roham T. Zamanian, Aaron B. Waxman, editors.
Contents:
Historical Perspective on the Classification and Nomenclature of Pulmonary Hypertension
The Defining Characteristics of Pulmonary Arterial Hypertension
Pulmonary Hypertension in Patients Without Pulmonary Arterial Hypertension
Epidemiology of Pulmonary Hypertension: From Quaternary Referral Centre to the Community
The Effects of Chronic Hypoxia on Inflammation and Pulmonary Vascular Function
Genetics of Pulmonary Vascular Disease
Novel Mechanisms of Disease: Network Biology and MicroRNA Signaling in Pulmonary Hypertension
Pulmonary Hypertension as a Metabolic Disease
Renin-Angiotensin-Aldosterone and other Neurohumoral Factors in the Pathogenesis of Pulmonary Hypertension
Animal Models of Pulmonary Hypertension
The Cardiopulmonary Hemodynamic Evaluation of Pulmonary Hypertension
Advanced Imaging in Pulmonary Hypertension
Assessing Disease State in the Pulmonary Vasculature in Clinical Practice and Research
Biomarkers and other Methods for Assessing Patient Progress
Pulmonary Circulatory
Right Ventricular Uncoupling: New Insights into Pulmonary Hypertension Pathophysiology
Contemporary Pharmacotherapies Involving Nitric Oxide, Prostacyclin, and Endothelin Receptor Signaling Pathways
Determining the Optimal Approach to Initiating Oral, Inhaled, and Intravenous Therapies in Clinical Practice: Sequential Goal-Directed Therapy is Best
Counterpoint: Determining the optimal approach to initiating oral, inhaled, and intravenous therapies in clinical practice: Maximal upfront therapy is best
Surgery, Devices, Transplantation and Other Interventional Options for the Treatment of Advanced Pulmonary Hypertension
Patient Registries in Pulmonary Arterial Hypertension: the Role of Survival Equations and Risk Calculators
Support Care for the Pulmonary Hypertension Patient
Special Considerations for the Pulmonary Hypertension Patient
The Future of Pulmonary Hypertension.